no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
An impact model to understand and improve work-life balance in early-career researchers in radiation oncology
|
Pittens, Carina |
|
|
37 |
C |
p. 101-108 |
article |
2 |
Combining androgen deprivation and radiation therapy in the treatment of localised prostate cancer: Summary of level 1 evidence and current gaps in knowledge
|
Baude, Jérémy |
|
|
37 |
C |
p. 1-11 |
article |
3 |
Dosimetric comparison of automatically propagated prostate contours with manually drawn contours in MRI-guided radiotherapy: A step towards a contouring free workflow?
|
Sritharan, Kobika |
|
|
37 |
C |
p. 25-32 |
article |
4 |
Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population
|
Fosså, Sophie D. |
|
|
37 |
C |
p. 78-84 |
article |
5 |
Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial
|
Swaminath, Anand |
|
|
37 |
C |
p. 145-152 |
article |
6 |
MRI-guided adaptive radiotherapy for prostate cancer: When do we need to account for intra-fraction motion?
|
Lawes, R. |
|
|
37 |
C |
p. 85-88 |
article |
7 |
Online MR guided dose escalated radiotherapy for organ preservation in distal rectal cancer
|
Boeke, Simon |
|
|
37 |
C |
p. 153-156 |
article |
8 |
Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial
|
Choi, J. Isabelle |
|
|
37 |
C |
p. 71-77 |
article |
9 |
Particle beam therapy for nasopharyngeal cancer: A systematic review and meta-analysis
|
Ng, Wai Tong |
|
|
37 |
C |
p. 41-56 |
article |
10 |
PEARLS – A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA‐avid pelvic and/or para-aortic lymph nodes at presentation
|
Murray, Julia |
|
|
37 |
C |
p. 130-136 |
article |
11 |
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)
|
Meattini, Icro |
|
|
37 |
C |
p. 94-100 |
article |
12 |
Real-world utilisation of brachytherapy boost and patient-reported functional outcomes in men who had external beam radiation therapy for prostate cancer in Australia
|
Ong, Wee Loon |
|
|
37 |
C |
p. 19-24 |
article |
13 |
Reduced-dose WBRT combined with SRS for 1–4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control
|
Nakano, Toshimichi |
|
|
37 |
C |
p. 116-129 |
article |
14 |
Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation
|
Herrera Siklody, C. |
|
|
37 |
C |
p. 89-93 |
article |
15 |
Replacing performance status with a simple patient-reported outcome in palliative radiotherapy prognostic modelling
|
Howdon, Daniel |
|
|
37 |
C |
p. 137-144 |
article |
16 |
Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial
|
Hannoun-Levi, Jean-Michel |
|
|
37 |
C |
p. 64-70 |
article |
17 |
Stereotactic body radiation therapy for spine and non-spine bone metastases. GETUG (french society of urological radiation oncologists) recommendations using a national two-round modified Delphi survey
|
Vilotte, F. |
|
|
37 |
C |
p. 33-40 |
article |
18 |
Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease
|
Willmann, Jonas |
|
|
37 |
C |
p. 12-18 |
article |
19 |
Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study
|
Kroese, Tiuri E. |
|
|
37 |
C |
p. 109-115 |
article |
20 |
The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy followed by durvalumab in patients with unresectable stage III non–small cell lung cancer: A multicenter retrospective cohort study
|
Takeda, Yuichiro |
|
|
37 |
C |
p. 57-63 |
article |